A Computational Approach to the Study of the Binding Mode of S1P1R Agonists Based on the Active-Like Receptor Model

被引:6
作者
Chen, Yonghui [1 ,2 ]
Liu, Tianqi [2 ,3 ]
Xi, Qiumu [2 ,3 ]
Jia, Wenqiang [1 ,2 ]
Yin, Dali [1 ,2 ,3 ]
Wang, Xiaojian [1 ,2 ,3 ]
机构
[1] Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China
[2] Chinese Acad Med Sci, Beijing 100050, Peoples R China
[3] Peking Union Med Coll, Inst Mat Med, Dept Med Chem, Beijing Key Lab Act Subst Discovery & Druggabil E, Beijing 100050, Peoples R China
基金
中国国家自然科学基金;
关键词
ACCELERATED MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; POTENT; IDENTIFICATION; DISCOVERY; MODULATOR; SWITCH; LOCK;
D O I
10.1021/acs.jcim.8b00764
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Sphingosine-1-phosphate receptor 1 (S1P(1)R), a member of the G protein-coupled receptor (GPCR) family, is an attractive protein target for the treatment of autoimmune diseases, and a diverse array of S1P(1)R agonists have been developed. Rational drug design based on S1P(1)R remains challenging due to the limited information available on the binding mode between S1P(1)R and its agonists. In this work, the active-like state of S1P(1)R was modeled via Gaussian accelerated molecular dynamics (GaMD) based on its inactive form, which was further validated by docking studies with two representative S1P(1)R agonists. Moreover, with the usage of the induced active-like state, the binding mode between S1P(1)R and its agonists was studied through molecular dynamics simulations and MM-GBSA calculations. The results of those studies indicated that four groups of binding site residues were the major contributors to the ligand and receptor interactions. In addition, this model was verified by five chemically similar compounds synthesized in-house and 1145 known S1P(1)R agonists collected from the BindingDB database. The elucidation of the key binding characteristics will further complete the cognition of S1P(1)R, which can guide the rational design of novel S1P(1)R agonists.
引用
收藏
页码:1624 / 1633
页数:10
相关论文
共 42 条
[1]   The universal protein resource (UniProt) [J].
Bairoch, A ;
Apweiler, R ;
Wu, CH ;
Barker, WC ;
Boeckmann, B ;
Ferro, S ;
Gasteiger, E ;
Huang, HZ ;
Lopez, R ;
Magrane, M ;
Martin, MJ ;
Natale, DA ;
O'Donovan, C ;
Redaschi, N ;
Yeh, LSL .
NUCLEIC ACIDS RESEARCH, 2005, 33 :D154-D159
[2]   Activation of the β2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6 [J].
Ballesteros, JA ;
Jensen, AD ;
Liapakis, G ;
Rasmussen, SGF ;
Shi, L ;
Gether, U ;
Javitch, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :29171-29177
[3]   Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders [J].
Buzard, Daniel J. ;
Thatte, Jayant ;
Lerner, Michael ;
Edwards, Jeffrey ;
Jones, Robert M. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (10) :1141-1159
[4]   Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor [J].
Buzard, Daniel J. ;
Kim, Sun Hee ;
Lopez, Luis ;
Kawasaki, Andrew ;
Zhu, Xiuwen ;
Moody, Jeanne ;
Thoresen, Lars ;
Calderon, Imelda ;
Ullman, Brett ;
Han, Sangdon ;
Lehmann, Juerg ;
Gharbaoui, Tawfik ;
Sengupta, Dipanjan ;
Calvano, Lorene ;
Montalban, Antonio Garrido ;
Ma, You-An ;
Sage, Carleton ;
Gao, Yinghong ;
Semple, Graeme ;
Edwards, Jeff ;
Barden, Jeremy ;
Morgan, Michael ;
Chen, Weichao ;
Usmani, Khawja ;
Chen, Chuan ;
Sadeque, Abu ;
Christopher, Ronald J. ;
Thatte, Jayant ;
Fu, Lixia ;
Solomon, Michelle ;
Mills, David ;
Whelan, Kevin ;
Al-Shamma, Hussien ;
Gatlin, Joel ;
Minh Le ;
Gaidarov, Ibragim ;
Anthony, Todd ;
Unett, David J. ;
Blackburn, Anthony ;
Rueter, Jaimie ;
Stirn, Scott ;
Behan, Dominic P. ;
Jones, Robert M. .
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (12) :1313-1317
[5]   Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases [J].
D'Ambrosio, Daniele ;
Freedman, Mark S. ;
Prinz, Joerg .
THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (01) :18-33
[6]  
Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022
[7]   Structural insights into agonist-induced activation of G-protein-coupled receptors [J].
Deupi, Xavier ;
Standfuss, Joerg .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2011, 21 (04) :541-551
[8]   Lipid14: The Amber Lipid Force Field [J].
Dickson, Callum J. ;
Madej, Benjamin D. ;
Skjevik, Age A. ;
Betz, Robin M. ;
Teigen, Knut ;
Gould, Ian R. ;
Walker, Ross C. .
JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2014, 10 (02) :865-879
[9]   Identification of the hydrophobic ligand binding pocket of the S1P1 receptor [J].
Fujiwara, Yuko ;
Osborne, Daniel A. ;
Walker, Michelle D. ;
Wang, De-an ;
Bautista, Debra A. ;
Liliom, Karoly ;
Van Brocklyn, James R. ;
Parrill, Abby L. ;
Tigyi, Gabor .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (04) :2374-2385
[10]   Molecular Determinants of Binding to the Plasmodium Subtilisin-like Protease 1 [J].
Fulle, Simone ;
Withers-Martinez, Chrislaine ;
Blackman, Michael J. ;
Morris, Garrett M. ;
Finn, Paul W. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2013, 53 (03) :573-583